JANE STREET GROUP, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 439 filers reported holding REPLIGEN CORP in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$4,282,934
+98.3%
26,935
+76.4%
0.00%0.0%
Q2 2023$2,159,670
-59.3%
15,267
-51.6%
0.00%
-50.0%
Q1 2023$5,307,718
+164.0%
31,526
+165.5%
0.00%
+100.0%
Q4 2022$2,010,726
-93.9%
11,876
-93.3%
0.00%
-92.9%
Q3 2022$33,084,000
+535.0%
176,815
+451.1%
0.01%
+600.0%
Q2 2022$5,210,000
-63.4%
32,084
-57.6%
0.00%
-50.0%
Q1 2022$14,249,000
-45.3%
75,759
-22.9%
0.00%
-50.0%
Q4 2021$26,038,000
-44.6%
98,317
-39.6%
0.01%
-52.9%
Q3 2021$47,035,000
+477.8%
162,758
+299.1%
0.02%
+466.7%
Q2 2021$8,141,000
-44.4%
40,778
-45.8%
0.00%
-62.5%
Q1 2021$14,636,000
+34.3%
75,288
+32.4%
0.01%
+60.0%
Q4 2020$10,898,000
+136.7%
56,867
+82.2%
0.01%
+66.7%
Q3 2020$4,605,000
-72.6%
31,214
-77.0%
0.00%
-75.0%
Q2 2020$16,799,000
+3575.9%
135,896
+2769.4%
0.01%
Q1 2020$457,000
-81.6%
4,736
-82.4%
0.00%
-100.0%
Q4 2019$2,487,000
+46.2%
26,891
+21.3%
0.00%0.0%
Q3 2019$1,701,000
+182.1%
22,177
+94.1%
0.00%
+200.0%
Q4 2018$603,000
+11.0%
11,427
+16.8%
0.00%0.0%
Q3 2018$543,000
+128.2%
9,782
-18.7%
0.00%
-50.0%
Q4 2014$238,00012,0260.00%
Other shareholders
REPLIGEN CORP shareholders Q1 2023
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders